Myometrics is a start up biotechnology company founded in 2007.
It is focused on the Discovery of therapies to treat diseases of
the neuromuscular and skeletal systems, and is also engaged in
providing CRO work for large pharmaceutical companies.
Myometrics has four drug discovery programs in the areas of:
- Periodontitis and implantology
- ALS (Lou Gehrig's Disease)
- Huntington's Disease
The staff at Myometrics have over forty years of combined experience
in small molecule pharmaceutical research. They have been
Prinicipal Investigators and Managers in a number of drug discovery
programs, ranging from product conception to supporting Phase III
If you are interested in talking to the staff at Myometrics to
discuss our work, please contact us at